Form 4: Hologic Director Wendell Acquires Stock and Options

Director Amy McBride Wendell reports acquisition of common stock and stock options in Hologic Inc.

Summary

• On February 26, 2025, Amy McBride Wendell, a director of Hologic Inc., acquired 1,864 shares of common stock.
• These shares were obtained through restricted stock units that vest on the date of the 2026 Annual Meeting of Stockholders and are settled in shares of common stock on a one-for-one basis.
• Wendell also acquired 5,535 non-qualified stock options with an exercise price of $64.36, which become exercisable on the date of the 2026 Annual Meeting of Stockholders and expire on February 26, 2035.
• Following these transactions, Wendell directly owns 22,594 shares of Hologic common stock and 5,535 derivative securities.

Sentiment

Score: 5

Explanation: The sentiment is neutral as it's a standard disclosure of insider trading activity. It doesn't inherently indicate positive or negative sentiment about the company's performance.

Industry Context

This filing is a routine disclosure of insider transactions, which are common in publicly traded companies. It provides transparency into the actions of company directors and their investment decisions.

Stakeholder Impact

• The acquisition of shares by a director can be viewed positively by shareholders as it aligns the director's interests with those of the shareholders.

Key Dates